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Abstract
Diisocyanate chemicals essential to polyurethane production are a well-recognized cause of 
occupational asthma. The pathogenesis of diisocyanate-induced asthma, including the pathways 
by which the chemical is taken up and its distribution in exposed tissue, especially the lung, 
remain unclear. We developed an antiserum with specificity for methylene diphenyl diisocyanate 
(MDI) the most abundantly produced and utilized diisocyanate world-wide, and established its 
ability to detect MDI in situ. Polyclonal MDI-specific IgG were induced by immunizing rabbits 
with MDI-conjugated to keyhole limpet hemocyanin (KLH) emulsified in complete Freund’s 
adjuvant, followed by two booster injections with incomplete Freund’s adjuvant. The antiserum 
contains IgG that recognize a variety of different MDI conjugated proteins, but not unconjugated 
or mock exposed proteins by dot blot analysis. The antiserum further demonstrates specificity for 
proteins conjugated with MDI, but not other commonly used diisocyanates. Immunochemical 
studies with cytospun airway cells and formalin-fixed paraffin embedded lung tissue sections from 
mice intranasally exposed to MDI (as reversibly reactive glutathione conjugates, e.g. GSH-MDI) 
demonstrated the antiserum’s ability to detect MDI in tissue samples. The data demonstrate 
penetration of MDI into the lower airways, localized deposition in the epithelial region 
surrounding airways, and uptake by alveolar macrophages. The new immunochemical reagent 
should be useful for further studies delineating the uptake and tissue distribution of MDI, 
especially as it relates to adverse health effects from exposure.
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1. INTRODUCTION
Diisocyanates, industrial chemicals with many important uses, are among the most 
commonly recognized causes of occupational asthma world-wide (Allport, Gilbert et al. 
2003, Wisnewski, Liu et al. 2008). Methylene diphenyl diisocyanate (MDI) is the most 
abundantly produced and consumed diisocyanate, with applications in the generation of 
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rigid foams and as a binding agent (Allport, Gilbert et al. 2003). Other diisocyanates, such as 
hexamethylene diisocyanate (HDI) and toluene diisocyanate (TDI) are less commonly used 
and have specialized applications as protective coatings and in the generation of “softer” 
flexible polyurethane foam (Allport, Gilbert et al. 2003, Wisnewski, Liu et al. 2008).
The pathogenesis of diisocyanate-induced asthma remains unclear, in part due to uncertainty 
regarding the reactivity of these chemicals with “self” molecules at the major sites of 
exposure. Animal studies with radio-isotope labeled diisocyanates suggest that a portion of 
inhaled chemical remains bound within lung tissue, however the distribution in different 
sub-anatomical locations remains unclear (Kennedy, Wilson et al. 1994). Redlich et al 
detected HDI along the airway epithelium of an exposed worker using polyclonal antiserum 
raised against HDI conjugated to ovalbumin (Redlich, Karol et al. 1997). Recent studies 
with TDI-specific monoclonal antibodies have demonstrated that TDI binds to proteins in 
the skin, which may be an important exposure route for inducing systemic immune 
sensitization (Nayak, Hettick et al. 2014). Studies detecting MDI in situ, however, are 
lacking, as necessary reagents have yet to be generated and characterized.
In this report, we develop a rabbit antiserum with specificity for MDI and demonstrate its 
utility for detecting the chemical in lung tissue from exposed animals. Importantly, the 
polyclonal serum includes anti-MDI IgG antibodies whose epitopes are not destroyed by 
formalin fixation, allowing immunochemical detection of MDI in samples processed 
according to routine histological procedures (e.g. formalin-fixed paraffin-embedded). The 
potential applications of the new anti-MDI polyclonal serum toward understanding disease 
pathogenesis and as evidence of chemical exposure are discussed.
2. METHODS
2.1 Chemicals and reagents
H2O2, the diisocyanates, 4,4′-diphenylmethane diisocyanate (MDI), 1,6 hexamethylene 
diisocyanate (HDI), and an 80:20 ratio mixture of 2,4:2,6 toluene diisocyanate (TDI), 
albumins (from human, bovine and mouse), tropomyosin, keyhole-limpet hemocyanin 
(KLH), Tween 20, tetramethylbenzidine (TMB) liquid substrate solution, complete and 
incomplete Freund’s adjuvant were from Sigma-Aldrich (St. Louis, MO). Biotin-labeled 
mouse monoclonal anti-rabbit IgG (6C1A8) with no cross-reactivity to IgG from other 
species was from ProSci Inc. (Poway, CA). Streptavidin-HRP and peroxidase conjugated 
anti-rabbit IgG were from BD Biosciences (San Jose, CA). Biotinylated goat anti-human 
albumin was from Bethyl (Montgomery, TX) and protein-A purified anti-IL-33 polyclonal 
rabbit IgG was from Enzo Life Sciences (Farmingdale, NY). Cyanogen bromide activated 
sepharose 4B was from Amersham Biosciences (Uppsala, Sweden) and protein A affinity 
columns were from BioRad (Hercules, CA). Biotin blocking solution was from Life 
Technologies (Eugene, OR). Diaminobenzidine (DAB) substrate, hematoxylin, and 
histomount were from a HistoMouse-MAX staining Kit (Invitrogen, Frederick, MD). 
Protein A sepharose 4B (InVitrogen). Normal rabbit and goat serum were from 
ThermoFisher Scientific (Waltham, MA). Amersham Hyperfilm MP from GE Healthcare 
Bio-Sciences (Pittsburgh, PA) was used in developing dot blots.
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2.2 Generation of diisocyanate-conjugated proteins
Diisocyanate conjugated proteins were prepared as previously described (Wisnewski, Liu et 
al. 2008, Wisnewski, Liu et al. 2010). Briefly, proteins were dissolved in 20 mM phosphate 
buffered saline pH 7.4 at a concentration of 5 mg/ml. Diisocyanates were prediluted to 10% 
w/v in acetone, and 10 μl/ml of 10% diisocyanate was added to protein solutions to achieve 
a final concentration of 0.1% (w/v) diisocyanate. Diisocyanate-protein reactions were mixed 
vigorously and rotated end-over-end for 2 hours at room temperature. Following 
centrifugation at 10,000 g, the supernatant was recovered and dialyzed against PBS to 
remove unreacted and/or hydrolyzed chemical as well as potential low molecular weight 
diisocyanate polymers. Following dialysis, samples were again centrifuged at 10,000 g, 
sterile filtered (0.2 μm), and stored at −80°C. Diisocyanate conjugation to proteins was 
verified by changes in the different proteins’ electrophoretic mobility and by mass 
spectrometry as previously described (Wisnewski, Liu et al. 2008, Wisnewski, Liu et al. 
2010). Control unconjugated proteins were “mock exposed” to 10 μl/ml of acetone without 
diisocyanate and identically processed.
2.3 Generation of polyclonal MDI-specific rabbit serum
To generate MDI-specific polyclonal rabbit serum, New Zealand White rabbits (Harlan 
Laboratories, Indianapolis, IN) were immunized subcutaneously with 500 μg of 4,4′-MDI-
conjugated KLH emulsified in complete Freund’s adjuvant, followed by two booster shots 
of 250 μg of MDI-KLH in incomplete Freund’s adjuvant on days 14 and 28. Terminal bleed 
serum was collected on day 72 from 2 different rabbits, pooled, and depleted of anti-KLH 
immunoglobulins by affinity chromatography using KLH-coupled sepharose 4B. For 
immunochemistry studies, the IgG fraction was further purified by protein A affinity 
chromatography. All animal studies were conducted in accordance with institutional 
guidelines.
2.4 Dot blot analyses
One microliter of protein solutions (5mg/ml, except for tropomyosin, 1 mg/ml) in PBS were 
spotted onto nitrocellulose membrane. Membranes were blotted with a 1:1000 dilution of 
anti-MDI polyclonal rabbit serum followed by a 1:2000 dilution of peroxidase conjugated 
anti-rabbit IgG. In studies with human albumin conjugated with different diisocyanates, dot 
blots were similarly probed with anti-MDI polyclonal serum, then subsequently stripped, 
and reprobed with biotinylated goat anti-human albumin, followed by peroxidase conjugated 
streptavidin. Replicate samples were also blotted with a 1:1000 dilution of pre-immune 
rabbit serum, normal rabbit serum and 2 μg/ml of polyclonal anti-IL-33 rabbit IgG. All bots 
were blocked with 3% dry milk in tris buffered saline (TBS) pH 7.4, washed with TBS 
containing 0.05% Tween 20, and developed with TMB liquid substrate, before exposure to 
film and processing. In some experiments, proteins were stained with 0.1% Ponceau S, and 
then washed before blotting with specific antibodies.
2.5 Immunochemistry
Studies were performed on replicate samples of cytospun airway cells obtained by 
bronchoalveolar lavage (BAL) and lung tissue sections of MDI exposed or control mice 
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acquired during prior studies as previously reported (Wisnewski, Liu et al. 2015). Cytospun 
BAL cells fixed with −20°C methanol and formalin-fixed paraffin-embedded tissue sections 
were blocked with 20% goat serum and stained with 2 μg/ml of KLH-depleted, protein-A 
affinity purified anti-MDI rabbit IgG, or 2 μg/ml of isotype control protein-A purified 
polyclonal rabbit IgG raised against IL-33 or 2 μg/ml protein-A purified normal rabbit IgG 
(not shown). Endogenous peroxidase was quenched before analysis using H2O2, and 
endogenous biotin was blocked before addition of biotin-labeled mouse monoclonal anti-
rabbit IgG (with no cross-reactivity to other species IgG) using commercially available 
“biotin-blocking solution” (see Section 2.1 above). Slides were further developed with 
peroxidase-labeled streptavidin, DAB substrate, and hematoxylin counterstain. Micrographs 
were taken under a Nikon Eclipse NI-U model microscope (Tokyo, Japan) equipped with a 
Nikon DS-Ri2 image capture system and loaded into Nikon’s NIS-Elements Basic Research 
software program for image analysis.
3. RESULTS
3.1 MDI antisera’s specificity for MDI conjugated vs. unconjugated proteins
The presence of MDI-specific IgG in the polyclonal rabbit serum was first assessed by dot 
blot analysis. As shown (Figure 1A and B) the MDI antisera contained rabbit IgG that 
recognized MDI in a hapten-like manner; the antisera bound to a variety of different MDI 
conjugated proteins, regardless of the protein “carrier”, but did not bind the corresponding 
unconjugated (mock reacted) proteins.
3.2 MDI antisera’s specificity for MDI vs. other diisocyanates
We next tested the specificity of the rabbit polyclonal antisera for MDI vs. other 
diisocyanates commonly used industrially, namely TDI and HDI. As shown (Figure 1C), the 
MDI antisera contained IgG that bound to albumin conjugated with MDI, but not HDI or 
TDI, or unconjugated (mock exposed) albumin preparations. In contrast, control biotinylated 
anti-human-albumin goat IgG recognizes albumin bound by all 3 diisocyanates; however 
binding is reduced following diisocyanate conjugation, likely due to chemical modification 
of the native albumin structure as previously described (Wisnewski, Liu et al. 2008, 
Wisnewski, Liu et al. 2010).
3.3. Detection of MDI within airway cells from MDI-GSH exposed mice
We tested the ability of the MDI antisera to detect MDI in airway cells recovered by 
bronchoalveolar lavage (BAL). Immunochemical staining of cytospun BAL cells from mice 
sensitized and exposed to MDI, as reversibly reactive MDI-GSH conjugates (Wisnewski, 
Liu et al. 2015), identified MDI primarily within the cytoplasm of cells with alveolar 
macrophage or dendritic cell morphology, but not polymorphonuclear or lymphocyte 
morphology (Figure 2). In contrast, no staining was observed in BAL cells recovered from 
MDI sensitized mice that had been exposed to inactivated (e.g. hydrolyzed) MDI.
3.4 Detection of MDI in lung tissue from MDI-GSH exposed mice
We further tested the ability of MDI antisera to detect MDI in situ in lung tissue from mice 
that had been exposed to MDI-GSH (Wisnewski, Liu et al. 2015). As shown in Figure 3, 
Wisnewski and Liu Page 4













immunochemical staining of formalin-fixed paraffin embedded tissue sections identified 
MDI localized primarily within epithelial cells, along the basement membrane lining the 
bronchial airways, and to a lesser extent, alveolar epithelial cells. Additional staining was 
also noted in cells that resemble alveolar macrophages, consistent with data from studies of 
BAL cells shown in Figure 2. The data validate the recently described effectiveness of 
delivering reactive MDI to the lower airways in rodents, via intranasal application of 
reversibly reactive MDI-GSH conjugates (Wisnewski, Liu et al. 2015).
4. DISCUSSION
The generation and characterization of a new immunologic reagent for the detection of MDI, 
an important occupational allergen, is described in this report. Anti-MDI polyclonal serum 
was developed by immunizing rabbits with KLH covalently conjugated with MDI, and 
subsequently evaluated via dot blots and immunocytochemical studies. The antiserum 
contains IgG that recognizes MDI in a hapten-like manner, and binds to MDI when 
conjugated to a diverse array of carrier proteins including albumin, tropomyosin, transferrin, 
and ovalbumin. The antiserum is specific for MDI, and does not cross-react with (proteins 
conjugated with) other commonly used isocyanates, including TDI and HDI. 
Immunocytochemical studies demonstrate the antiserum’s capacity to detect MDI in situ in 
formalin-fixed paraffin-embedded tissue sections from the lungs of exposed animals. The 
new reagent will serve as a useful probe for research studies evaluating the pathogenesis of 
MDI exposure induced asthma, especially the uptake and distribution of chemical, which 
continues to remain unclear despite decades of research.
The present immunocytochemical studies with anti-MDI polyclonal antiserum expand upon 
recent studies demonstrating the capacity of reversibly reactive MDI-GSH conjugates to 
induce eosinophilic airway inflammation in sensitized animals (Wisnewski, Liu et al. 2015). 
The data confirm penetration of MDI to the lower airways following intranasal application 
of MDI-GSH conjugates under light anesthesia; unlike prior studies, which have found 
limited lower airway penetration of pure isocyanate vapors (or solutions in organic solvent), 
presumably due to the scrubbing effects of rodent upper airways (Kennedy, Singh et al. 
1993, Kennedy, Wilson et al. 1994, Pauluhn 2014). The findings validate the hypothesis that 
MDI-GSH conjugates provide an effective approach for delivering a reactive form of MDI 
to the lower airways, overcoming barriers that have limited animal studies of MDI asthma 
pathogenesis in the past.
The present data identify airway cells, airway basement membrane, alveolar macrophages, 
and to a lesser extent alveolar epithelial cells, as targets for MDI in the lower airway. These 
findings are consistent with limited prior studies in humans, biophysical aspects of the 
airway microenvironment, and accumulating data on monocyte/macrophage responses to 
isocyanates in vitro and in vivo (Redlich, Karol et al. 1997, Wisnewski, Liu et al. 2008, 
Wisnewski, Liu et al. 2015). Airway epithelial cells have been hypothesized as a primary 
reaction target for diisocyanates given their location at the air/liquid interface of the lung. 
Isocyanate reactivity with human airway cells in vivo and in vitro has been reported 
following HDI exposure, but similar studies have not been undertaken with MDI (Redlich, 
Karol et al. 1997). Reactivity of MDI with the bronchial basement membrane has not been 
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previously recognized, but specific components, including laminin and elastin have been 
proposed as targets for diisocyanate conjugation (Nayak, Hettick et al. 2014, Hulst, 
Verstappen et al. 2015). Deposition of isocyanate along the bronchial basement membrane 
might result in a stable/persistent reaction product capable of eliciting immune responses 
long after exposure ceases. Uptake of MDI by alveolar macrophages is consistent with the 
well-recognized phagocytic capacity of these cells and their role in airway homeostasis. The 
effects of MDI (and other diisocyanates) on airway monocytes/macrophages and related 
antigen presenting cells remains unclear, but could play an important role in asthma 
pathogenesis (Wisnewski, Liu et al. 2015). In vitro studies with human monocytes that have 
phagocytized isocyanate conjugated proteins have documented marked changes in gene 
expression patterns, some of which have been linked to adverse clinical outcomes from 
occupational diisocyanate exposure (Wisnewski, Liu et al. 2008). Thus, the present 
immunocytochemical identification of MDI in situ in the lungs of animals exposed to MDI 
(as reversibly reactive GSH conjugates) validates limited prior studies, and leading 
hypotheses on chemical reactivity/deposition in vivo.
In summary, a new antiserum was developed with specificity for the occupational allergen, 
MDI, a chemical essential to numerous industrial processes. The polyclonal antiserum 
contains IgG that recognize MDI in a hapten-like manner and demonstrates utility for 
localizing the chemical in situ in tissue samples processed for routine histology (e.g. 
formalin-fixed paraffin embedded). The new MDI antiserum will be useful for future studies 
delineating the uptake and distribution of MDI, especially as it relates to the development of 
asthma and other adverse exposure outcomes.
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Specificity of MDI antisera. Different MDI-conjugated (+ MDI) or unconjugated/mock 
exposed (− MDI) proteins were spotted onto nitrocellulose membranes, stained for total 
protein using Ponceau-S (Panel A), and then blotted (Panel B) with a 1:1000 dilution of 
polyclonal anti-MDI serum, and reagents to detect rabbit IgG. In Panel C, mock exposed 
control albumin samples, or albumin conjugated with MDI, TDI or HDI (as labeled) were 
spotted onto nitrocellulose membranes and probed with MDI antisera or biotinylated anti-
human albumin (as labeled) and developed with reagents that detect rabbit IgG or biotin 
respectively. No signal was observed in dot blots with control, pre-immune, normal rabbit 
serum, or polyclonal rabbit anti-IL-33 (data not shown).
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Immunochemical detection of MDI in BAL cells. Lower airway cells from MDI skin 
sensitized mice exposed to inactivated (hydrolyzed) MDI (Panels A & B) or MDI-GSH 
(Panels C & D) were stained with protein-A affinity purified control (anti-IL-33) rabbit 
polyclonal antisera (Panels A & C) or KLH-depleted, protein-A affinity purified MDI 
antisera (Panels B & D). Note dark staining within cytoplasm of cells with alveolar 
macrophage and dendritic cell-like morphology.
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Immunochemical detection of MDI in situ in the airway. Lung tissue sections from mice 
exposed via the airways to control inactivated (e.g. hydrolyzed) MDI (A, B) or MDI-GSH 
conjugates (C–H) were stained with control (anti-IL-33) rabbit serum (A, C, E) or anti-MDI 
rabbit serum (B, D, F, G, H) as described in the methods section and detected via DAB 
(brown) peroxidase stain, with blue hematoxylin counter stain. Panels A–F were 
photographed under 200X magnification. Panels G and H, taken under 1000X 
magnification, highlight areas shown in the rectangles in Panels D and F respectively. 
Arrows highlight staining of cells lining the airways, the basement membrane and an 
alveolar macrophage.
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